Sandeep Khosla, MD
Interventional Cardiology · Chicago, ILNPI 1376544312
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,491 and has fallen 81.7% since, to $273 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IL, where the typical reported total is $7,434.
Across 284 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Abiomed$844
- Novartis$709
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$493
- Merck$406
- Boehringer Ingelheim$366
- plus $2K from 22 others
Across 40 payments — averaging $5553.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$125K
- Novartis$45K
- American Regent$33K
- AstraZeneca$10K
- Organon$8K
What the payments were for
- Food & beverage$6,24699%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 43 | $1,054 |
| Abiomed | 26 | $844 |
| Novartis | 36 | $709 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $493 |
| Merck | 24 | $406 |
| Boehringer Ingelheim | 16 | $366 |
| Medtronic(2 entities) | 19 | $356 |
| Pfizer | 12 | $292 |
| AstraZeneca | 15 | $285 |
| E.r. Squibb & Sons, L.L.C. | 16 | $235 |
| Boston Scientific | 5 | $199 |
| Amgen | 8 | $183 |
| Penumbra, Inc. | 2 | $150 |
| Bayer | 5 | $139 |
| Abbott | 4 | $96 |
| Esperion Therapeutics, Inc. | 4 | $87 |
| Cook Medical LLC | 4 | $80 |
| Astellas Pharma US Inc | 3 | $57 |
| Cardiovascular Systems Inc. | 3 | $51 |
| Lantheus Medical Imaging, Inc. | 3 | $50 |
| Inari Medical, Inc. | 2 | $38 |
| Shockwave Medical, Inc | 1 | $29 |
| Baxter Healthcare | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Seagen Inc. | 1 | $20 |
| Preventice Services, LLC | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $18 |
| Acist Medical Systems, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$149
- Indigo System$141
How this compares
$6,316 in reported general payments places this provider in the 40th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Chicago
- Atman ShahChicago$788K
- David StewartChicago$169K
- Hussam SuradiChicago$97K
- Anita AsgarChicago$85K
- Daniel SchimmelChicago$79K
- Ranya SweisChicago$62K
- Charles DavidsonChicago$62K
- Fareed Moses ColladoChicago$42K
- James FlahertyChicago$38K
- Ashvarya ManglaChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.